Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors
Computational and Structural Biotechnology Journal · 2024-12 · 23 · 2964-2977
DOI: 10.1016/j.csbj.2024.07.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Computational and Structural Biotechnology Journal, online erschienen am 06.07.2024. Verfasst von Adeshina I Odugbemi und 3 weiteren Autor:innen. Beteiligte Einrichtung: South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellvill…. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation.
Abstract (Originalsprache)
Artificial Intelligence is transforming drug discovery, particularly in the hit identification phase of therapeutic compounds. One tool that has been instrumental in this transformation is Quantitative Structure-Activity Relationship (QSAR) analysis. This computer-aided drug design tool uses machine learning to predict the biological activity of new compounds based on the numerical representation of chemical structures against various biological targets. With diabetes mellitus becoming a significant health challenge in recent times, there is intense research interest in modulating antidiabetic drug targets. α-Glucosidase is an antidiabetic target that has gained attention due to its ability to suppress postprandial hyperglycaemia, a key contributor to diabetic complications. This review explored a detailed approach to developing QSAR models, focusing on strategies for generating input variables (molecular descriptors) and computational approaches ranging from classical machine learning algorithms to modern deep learning algorithms. We also highlighted studies that have used these approaches to develop predictive models for α-glucosidase inhibitors to modulate this critical antidiabetic drug target.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- South African Medical Research Council Bioinformatics Unit, South African National Bioinformatics Institute, University of the Western Cape, Bellville, Cape Town 7535, South Africa.
- School of Pharmacy, University of the Western Cape, Bellville, Cape Town 7535, South Africa.
- National Institute for Theoretical and Computational Sciences (NITheCS), South Africa.
- Department of Computer Science, University of the Western Cape, Cape Town 7535, South Africa.
- Africa Centres for Disease Control and Prevention, African Union, Addis Ababa, Ethiopia.
Förderung
- National Research Foundation
Zitieren
APA
Odugbemi, A. I., Nyirenda, C., Christoffels, A., & Egieyeh, S. A. (2024). Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors. Computational and Structural Biotechnology Journal, 23, 2964-2977. https://doi.org/10.1016/j.csbj.2024.07.003
Vancouver
Odugbemi AI, Nyirenda C, Christoffels A, Egieyeh SA. Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors. Computational and Structural Biotechnology Journal. 2024;23:2964-2977. doi:10.1016/j.csbj.2024.07.003
BibTeX
@article{Odugbemi2024,
author = {Odugbemi, Adeshina I and Nyirenda, Clement and Christoffels, Alan and Egieyeh, Samuel A},
title = {Artificial intelligence in antidiabetic drug discovery: The advances in QSAR and the prediction of α-glucosidase inhibitors},
journal = {Computational and Structural Biotechnology Journal},
year = {2024},
volume = {23},
pages = {2964--2977},
doi = {10.1016/j.csbj.2024.07.003}
}
EUVIMED